ELMSFORD, N.Y.--(BUSINESS WIRE)--In remarks at the annual stockholders’ meeting, Chairman and Chief Executive Officer, Richard H. Friedman set forth BioScrip’s (NASDAQ: BIOS) 2007 key goals and objectives as well as its growth initiatives. Mr. Friedman was quoted as saying that “For the past year, as we have met head on the challenges of integrating MIM Corporation and Chronimed, it has been my job to restore shareholder value while protecting the reputations, customers, patients and revenue base of our two highly specialized brands.”
